Globally big Indian Biopharmaceutical companies are also keeping eyes to patent their biological inventions to increase their longevity and monopoly in the market. Unfortunately, there are no clear criteria's for patentable matters in biotechnological inventions under Indian patent act 2005.Gupta, ...
Indian Patent ActRevealed comparative advantageExportImportTrade specialisation coefficientPurpose – The purpose of this paper is to examine the trade performance, revealed comparative advantage and trade specialisation indices of Indian pharmaceutical in the post-modified Indian Patent Act. Design/methodology...
India, China, others move to counter US, EU patent pressure 07 March 2017 Delhi HC allows Biocon, Mylan to sell generic drug for three types of cancers 04 March 2017 NPPA to meet stent manufacturers as hospitals continue to flout order 03 March 2017 India beware: WHO publishes list of...
Amendment to UK Patent Act provides further exception to patent infringement The UK government has recently scheduled an amendment to the 1977 Patents Act, which would exempt activities involved in preparing or running clinical tria... A Sklan - 《Pharmaceutical Patent Analyst》 被引量: 0发表: 20...
The Court has the power to review its rulings to correct a “patent error” and not “minor mistakes of inconsequential import”. A review is by no means an appeal in disguise. That means the Court is allowed not to take fresh stock of the case but to correct grave errors that have ...
Ko RJ. Adulterants in Asian patent medicines. N Engl J Med. 1998;339(12):8479750079PubMedGoogle ScholarCrossref 22. Baer RD, Ackerman A. Toxic Mexican folk remedies for the treatment of empacho: the case of azarcon, greta and albayalde. J Ethnopharmacol. 1988;24(1):31-393199838PubMed...
Patentability of medical devices The Patents Act grants a patent to 'inventions' which is "a new product or process involving an inventive step12 and capable of industrial application13." However, some innovations though falling within the definition of invention above, would not be considered to ...
d) infringes any patent, trademark, copyright or other proprietary rights; e) violates any law for the time being in force; f) deceives or misleads the addressee about the origin of such messages or communicates any information which is grossly offensive or menacing in nature; g) impersonate...
The United States Patent and Trademark Office has developed an action plan to respond to the new issues concern business method patents; http://www.uspto.gov/web/offices/com/sol/actionplan.html. 81 Guidelines for Examination in the European Patent Office, Part C, Chapter IV, 1. General. 37...
United States Patent 10864420 Abstract: Aspects of the disclosure include a basketball goal assembly with a vertical support assembly formed with a lower support assembly and an upper support assembly. The basketball goal assembly facilitates packaging, transport, display and installation of the assembly...